Texas Woman Files Reglan Lawsuit

A Texas woman has filed a Reglan side effects lawsuit against Wyeth and other pharmaceutical companies responsible for the manufacture and distribution of the gastrointestinal drug. The lawsuit, filed in the District Court for the Northern District of Texas (Amarillo Division), outlines plaintiff Glenda S. Howell's struggle with Reglan side effects. 

Reglan tardive dyskinesia in lawsuit

Plaintiff Howell filed her Reglan lawsuit with a Reglan lawyer after experiencing side effects that have been linked to the medication, namely Reglan tardive dyskinesia. Tardive dyskinesia is a neurological movement disorder that affects patients, especially muscles in the face. Victims of tardive dyskinesia have uncontrollable twitching, movements, or tics in a number of muscles, which can include involuntary eye movements, face movements, mouth tics or tongue protrusions, and other side effects. There is no cure and it usually stays with a patient for life. 

Reglan Supreme Court Decision Affects Lawsuits

The Supreme Court recently made a groundbreaking decision that is set to have a significant impact not only on Reglan lawsuits, but on a number of future side effects lawsuits. In June of 2011, the Supreme Court of the United States voted on a case called PLIVA v. Mensing, having to do with generic manufacturers of medications, namely the generic form of acid reflux drug Reglan, the generic of which is called metaclopramide. The Supreme Court voted that, as long as the labeling of the generic product exactly matched that of the name-brand drug, generic manufacturers could not be held liable in side effects lawsuits. 

Reglan Side Effects Cases Thrown Out, Could Be Re-Filed

A woman who filed a Reglan tardive dyskinesia case has had her case dismissed from court without prejudice, meaning the door remans open for further litigation in her case in the future. Virginia Carswell filed a lawsuit against five defendants, all companies that have something to do with the manufacture, marketing, or sale of Reglan and the generic equivalent, metoclopramide. The lawsuit, filed on the 27th of May in 2011, cited the fact that Reglan can lead to serious side effects for some patients.

Long Term Use of Reglan Leads to Rising Number of Lawsuits

Use of the gastrointestinal drug Reglan, and other generic drugs containing Metoclopramide, can cause a disabling neurological syndrome known as Reglan tardive dyskinesia, which involves involuntary and repetitive movements that can be permanent. These Reglan neurological problems are devastating and socially disabling, causing severe physical, mental, social and emotional suffering. In February 2009, the U.S. Food & Drug Administration (FDA) mandated that the makers of Reglan add a black box warning to its label regarding the risk of tardive dyskinesia associated with chronic, long-term use. The FDA’s mandate followed the publication of analyses that suggested that Reglan is the most common cause of drug-induced movement disorders. 

To prevent tardive dyskinesia and other Reglan side effects, the drug should not be taken for more than 12 months, and it has not been approved for longer user. However, it has become

Reglan Settlements Possible Over Neurological Movement Disorders

Reglan is a relatively harmless drug when it is taken for a brief period of time. It is used to treat gastrointestinal conditions that make it difficult to digest food or keep food down, and can help people with certain types of diabetes and even morning sickness from pregnancy. If a patient takes the medication for twelve weeks or less, there is a relatively low rate of Reglan side effects experienced by the patient. However, almost one in three Reglan patients take the medication for much longer than twelve weeks—and these patients are much more likely to suffer from debilitating and painful side effects.

Reglan side effects usually involve Reglan neurological problems, the most common of which is tardive dyskinesia. The symptoms of Reglan tardive dyskinesia include, but are not limited to, spasms and tics of the facial area, which are involuntary. Lip puckering, protrusions of the tongue, and rapid eye blinking are telltale signs of tardive dyskinesia.

Reglan Lawsuits Over Tardive Dyskinesia

Lawsuit filed against Reglan by Reglan lawyer. There are more than 2 million American patients still using the controversial gastrointestinal drug Reglan, which contains a chemical discovered in the 1960s but was shelved in a backseat position after a competing drug was discovered in the 1990s. After that drug, Cisapride, was discontinued because it was linked to cardiac arrhythmia, Reglan was pushed to the forefront once again. Now the drug is in the media for another time, because of Reglan side effects in children —namely, tardive dyskinesia, a movement disorder that affects the muscles in the face and limbs.

Reglan neurological problems: Patients with tardive dyskinesia often will not be able to find a treatment because there is no confirmed treatment or cure for the condition.

Generic Reglan Lawsuits In Question While Brand Name Lawsuits Still In Court

In a devastating opinion for consumers, the Supreme Court has ruled that generic drug companies cannot be held liable for failing to warn about known side effects of medications they sell, so long as their labels are identical to those of the original brand-name product.  The ruling may have an impact on thousands of generic drug lawsuits filed throughout the United States, involving problems with generic versions of drugs like Reglan, Accutane, Darvocet, Zocor and others. In the recent Reglan lawsuit brought to trial,  the 5-4 decision in Pliva Inc. v. Mensing was handed down by the Supreme Court today, split along ideological lines among the justices.

The case before the court, Pliva Inc. v. Mensing, involved metoclopramide, which is sold under the brand name Reglan. Reglan was approved in 1980 as a treatment for digestive track problems. Two women had sued Croatia-based Pliva Inc. and other generic drug manufacturers for failing to provide warnings about Reglan tardive dyskinesia. Reglan did